Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
124.3 USD | -9.91% | -4.87% | +0.20% |
26.04. | DEXCOM, INC. : Morgan Stanley gibt eine Kauf-Bewertung ab | ZM |
26.04. | DEXCOM, INC. : Canaccord Genuity gibt neutrale Bewertung ab | ZM |
ETFs investiert in DexCom, Inc.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
1,46% | 18 M€ | +3.79% | - | |
1,04% | 16 M€ | -8.49% | ||
0,96% | 1 182 M€ | +1.06% | ||
0,95% | 2 M€ | -1.17% | - | |
0,77% | 2 M€ | +6.77% | ||
0,61% | 4 M€ | +20.15% | ||
0,40% | 5 M€ | -72.95% | - | |
0,40% | 3 M€ | 0.00% | - | |
0,36% | 9 M€ | -.--% | - | |
0,31% | 22 M€ | 0.00% | - | |
0,31% | 40 M€ | -.--% | ||
0,28% | 219 M€ | +17.17% | - | |
0,28% | 1 448 M€ | -.--% | - | |
0,25% | 2 510 M€ | +12.00% | ||
0,21% | 330 M€ | -.--% | - | |
0,19% | 2 M€ | +14.69% | - | |
0,17% | 276 M€ | +11.40% | - | |
0,17% | 36 M€ | -.--% | ||
0,17% | 277 M€ | -.--% | - | |
0,17% | 194 M€ | +7.48% | - | |
0,17% | 441 M€ | +10.26% | ||
0,15% | 374 M€ | +15.20% | - | |
0,14% | 6 M€ | +17.98% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+0.20% | 49.45 Mrd. | |
-2.31% | 187 Mrd. | |
-3.20% | 106 Mrd. | |
-5.04% | 66.9 Mrd. | |
+17.29% | 48 Mrd. | |
+4.06% | 40.84 Mrd. | |
+2.36% | 26.25 Mrd. | |
+2.07% | 26.48 Mrd. | |
+12.96% | 24.62 Mrd. | |
-1.93% | 24.52 Mrd. |
- Börse
- Aktien
- A0D9T1 Aktie
- ETFs DexCom, Inc.